Navigation Links
Safe to Stop the Flow?: Differing Attitudes Found Between Women and Doctors Concerning Menstrual Suppression
Date:10/3/2007

Two Thirds of Women Interested in Stopping their Periods, But Unsure About Medical Implications

PHILADELPHIA, Oct. 3 /PRNewswire-USNewswire/ -- More than two thirds of women in a national survey say that they are interested in suppressing their menstrual periods but many of them aren't sure if it's safe. Yet when physicians are polled, 97 percent say that continuous oral contraceptive therapy to suppress menstruation is, in fact, medically safe and acceptable. The survey results were presented by Kurt Barnhart MD, MSCE from the University of Pennsylvania School of Medicine at the Association of Reproductive Health Professionals' (ARHP) Reproductive Health 2007 conference.

"The gap between physician and patient understanding concerning the necessity of monthly periods is obvious," said Dr. Barnhart, Associate Professor and Director of Clinical Research for the Department of Obstetrics & Gynecology. "It is our hope that based on these findings physicians will begin to more readily initiate dialogue with their female patients about continuous therapy -- helping to eliminate the misconception that periods are a medical necessity and to emphasize the safety and viability of menstrual suppression."

Multiple oral contraceptives are already available to reduce menstruation and the FDA recently approved the first continuous oral contraceptive designed to suppress a woman's menstrual cycle. And according to this study, women are increasingly interested in exercising their options. The study found that 63 percent of women reported being extremely or somewhat interested in not having a period. Symptoms cited as the most bothersome aspects of menstruation included cramping, mood swings, bloating and headaches/body aches, while associated personal frustrations cited included avoiding exercise and sexual intercourse, eating more and a decrease in work productivity.

Why would a physician recommend a woman suppress her menses?

"The symptoms that often accompany menstruation - from depression to bloating and headaches - can significantly disrupt women's lives," said Dr. Barnhart. "Menstruation is not medically necessary. Now that we have products that have proven to be safe and effective at suppressing menstruation, we can offer increasing options for women."

Indeed it seems a clearer patient-physician dialogue is required to eliminate confusion regarding menstrual suppression and continuous use oral contraceptives. Of the 12% of patients who indicated that they have discussed the idea of eliminating or reducing periods with their doctor; nearly half of those said that they were the ones to raise the issue, not their physicians. But their physicians tell a different story. By contrast, four out of 5 physicians reported discussing continuous use oral contraceptive use with their patients, and 77% reported that they raised the topic.

This disconnect may be related to simple semantics, according to Dr. Barnhart.

"We've found that physicians and their patients discuss this topic differently, with doctors using the medical term menstrual suppression, while their patients simply talk about not having a period," he said. "Breaking down this language barrier by speaking in simpler, more patient-friendly terms could have a significant positive impact on understanding."

Oral contraceptives were initially designed with a week of inactive tablets taken every month to mimic the natural experience of menstruation. Continuous use oral contraceptives simply eliminate these inactive tablets, thereby eliminating withdrawal bleeding. A study published in the December, 2006 issue of Contraception demonstrated the safety and effectiveness of continuous-use oral contraceptives that can eliminate menstrual cycles. Researchers concluded that a continuous-use, low-dose regimen of oral contraceptives was safe and as effective as traditional oral contraceptives, and that the decrease in menstrual cycle symptoms during continuous use therapy represented an increase in quality of life.

Editor's note: Study findings are based on research conducted by Wyeth Pharmaceuticals. Dr. Barnhart has served as a consultant to Wyeth Pharmaceuticals.

PENN Medicine is a $3.5 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is currently ranked #3 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals -- its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation's "Honor Roll" hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center -- a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.


'/>"/>
SOURCE University of Pennsylvania Health System
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Differing reactions to anti clotting drugs may be due to genetic variation.
2. Differing Ideas on Management of Alzheimer’s diseas
3. Risk Attitudes And Consequences Of College Drinking
4. Attitudes About Aging Different from Reality
5. Sexual Attitudes Help Explain Narcissists’ Relationship Problem
6. Men and Women Change Attitudes to Sex When in an Intimate Relationship
7. High-risk Sexual Behavior Adolescents Attract Peers With Similar Attitudes
8. Distraction therapy found very effective in postoperative patients
9. Genetic differences found between Male and Female brains
10. Breastfeeding not found to have an impact on weight of the child.
11. Common Cold Found to Fight Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... scholarships to students studying complementary medicine. Allison Outerbridge is this year’s Life ... award on May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, ... defective respirators, according to court documents and SEC filings. A jury has ... Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The ...
(Date:5/26/2016)... ... 2016 , ... The Woodlands at John Knox Village , Florida’s first ... for living and healing, celebrated its grand opening, today. The Woodlands at John Knox ... by Empowered Staff. , “This is an incredibly fulfilling time for John Knox Village ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 ARANZ Medical  Ltd ... healthcare sector, has been named the Coretex Hi-Tech Emerging Company ... Dr Bruce Davey , CEO of ARANZ ...  It,s really good to be recognised for the work we ... are used in 35 countries around the world from Sub-Saharan ...
(Date:5/24/2016)... BioMarketing as senior vice president of sales, announced Andrea Heslin Smiley , VMS ... company,s business development and sales team, exploring new opportunities for VMS to empower patients ... ... ... ...
(Date:5/24/2016)... May 24, 2016 ... , la première endoprothèse à double ... à l,intervention portant sur les membres inférieurs ... OrbusNeich, entreprise mondiale spécialisée dans la ... la vie, a élargi son portefeuille pour ...
Breaking Medicine Technology: